Back to Journals » Clinical Ophthalmology » Volume 5

Hemiretinal vein occlusion with macular hemorrhage and edema treated with intravitreal bevacizumab

Authors Yalamanchi S, Flynn Jr. H

Published 14 October 2011 Volume 2011:5 Pages 1509—1513


Review by Single anonymous peer review

Peer reviewer comments 4

Shalini Yalamanchi, Harry W Flynn Jr.
Department of Ophthalmology, Bascom Palmer Eye Institute, Miami Miller School of Medicine Miami, FL, USA

Abstract: A 39-year-old male with decreased visual acuity and extensive macular hemorrhage and edema secondary to a hemiretinal vein occlusion was treated with multiple intravitreal injections of bevacizumab 1.25 mg every four to six weeks for over one year. Treatment outcomes were assessed by visual acuity and Cirrus spectral domain optical coherence tomography. Treatment resulted in ongoing visual and anatomic improvement, with resolution at the last visit.

Keywords: retinal vein occlusion, macular edema, bevacizumab

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]